PCRX
Pacira BioSciences, Inc. · Healthcare
Director John P Phd Longenecker sold $502K of Pacira BioSciences, Inc.
Sold$502,145
$71.74Price
7,000Shares
−27%Stake
What PCRX did after the filing
- The stock from Mon, Mar 7 close, $71.20
- +3.9%
- S&P 500, same days
- +6.4%
Measured over 30 trading days, to the Apr 19 close.
Traded Thu, Mar 3. Filed Mon, Mar 7, 3:03 PM ET, during the session. Returns use the Mar 7 close and the Apr 19 close. Not investment advice.